FDA.reportPublic FDA data

benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution

RxCUI
2099132
RxNorm name
benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution
Display name
benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution
Full name
benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALTAFLUORFLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDEAltaire Pharmaceuticals Inc.54017304-e680-4129-b52a-69cb9810af762017-12-06Warnings, Adverse reactionsExact identifier
rxcui: 2099132

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
54017304-e680-4129-b52a-69cb9810af76benoxinate HCl 0.4 % / fluorescein sodium 0.25 % Ophthalmic Solution [PSN] · benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution [SCD] · benoxinate hydrochloride 0.4 % / fluorescein sodium 0.25 % Ophthalmic Drops [SY]35These highlights do not include all the information needed to use ALTAFLUOR BENOX safely and effectively. See full prescribing information for ALTAFLUOR BENOX. Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/ 0.4% for topical ophthalmic use Initial U.S. Approval: 201720171206